Site icon Wonderful Engineering

This Startup Claims To Reverse Ageing By Filling Your Veins With Young People’s Blood

Say hello to Jesse Karmazin – a startup founder and Stanford Medical School graduate – who is making big bucks on an absurd idea. Karmazin launched Ambrosia about three years ago. The startup filled the veins of older people with blood that came from younger donors. This process was carried out with the hope that it would help conquer ageing.

However, there is almost little to no evidence that suggests that such a feat is even possible. The basic idea is to rejuvenate the organs of a body by providing it younger blood. The company, Ambrosia, is nonetheless up and running. It recently revamped its website with a list of its clinics and locations, spread over the US in five different cities. The company is accepting payments for the procedure via PayPal. The two options being offered are $8,000 for a liter and $12,000 for two liters.

Fun fact; Karmazin is not a licensed medical practitioner. Nonetheless, he has managed to open clinics in Los Angeles, San Francisco, Tampa, Florida, Omaha, Houston, and Nebraska. Ambrosia took out trials back in 2017 where it tried to determine what happened to the patients that had blood added to their systems. The results of the study have not been made public, but Karmazin claims that the results were ‘really positive’.

David Cavalier is Ambrosia’s chief operating officer, and while speaking about the clinical trial back in September last year, said, ‘The trial was an investigational study. We saw some interesting things, and we do plan to publish that data. And we want to begin to open clinics where the treatment will be made available.’

Karmazin says, ‘Some patients got young blood, and others got older blood, and I was able to do some statistics on it, and the results looked really awesome. And I thought this is the kind of therapy that I’d want to be available to me.’ As of right now, no one can be certain of the benefits that this procedure offers if any. Nonetheless, Karmazin says, ‘I’m really happy with the results we’re seeing.’